DE69913369D1 - Mikrobielle transformationsprodukte - Google Patents

Mikrobielle transformationsprodukte

Info

Publication number
DE69913369D1
DE69913369D1 DE69913369T DE69913369T DE69913369D1 DE 69913369 D1 DE69913369 D1 DE 69913369D1 DE 69913369 T DE69913369 T DE 69913369T DE 69913369 T DE69913369 T DE 69913369T DE 69913369 D1 DE69913369 D1 DE 69913369D1
Authority
DE
Germany
Prior art keywords
microbial transformation
transformation products
hydroxysordarin
sordarin
atcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69913369T
Other languages
English (en)
Other versions
DE69913369T2 (de
Inventor
G Sturr
M Chartrain
H Harris
Jennifer Nielsen-Kahn
Brian Heimbuch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69913369D1 publication Critical patent/DE69913369D1/de
Publication of DE69913369T2 publication Critical patent/DE69913369T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69913369T 1998-10-26 1999-10-22 Mikrobielle transformationsprodukte Expired - Fee Related DE69913369T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10566998P 1998-10-26 1998-10-26
US105669P 1998-10-26
PCT/US1999/024865 WO2000024728A1 (en) 1998-10-26 1999-10-22 Microbial transformation product

Publications (2)

Publication Number Publication Date
DE69913369D1 true DE69913369D1 (de) 2004-01-15
DE69913369T2 DE69913369T2 (de) 2004-10-14

Family

ID=22307127

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69913369T Expired - Fee Related DE69913369T2 (de) 1998-10-26 1999-10-22 Mikrobielle transformationsprodukte

Country Status (9)

Country Link
US (1) US6228622B1 (de)
EP (1) EP1124813B1 (de)
JP (1) JP2002528444A (de)
AT (1) ATE255572T1 (de)
AU (1) AU760975B2 (de)
CA (1) CA2347803A1 (de)
DE (1) DE69913369T2 (de)
ES (1) ES2211191T3 (de)
WO (1) WO2000024728A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160441A1 (en) * 1998-06-02 2002-10-31 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
WO2003007878A2 (en) * 2001-07-18 2003-01-30 Merck & Co., Inc. Antifungal agents of sordarin derivatives
US20040242904A1 (en) * 2001-12-14 2004-12-02 Angelo Basilio Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
CN101807621B (zh) * 2009-02-18 2012-01-18 财团法人工业技术研究院 太阳能电池模块修复装置与修复方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
EP0712859A1 (de) * 1994-11-08 1996-05-22 Glaxo, S.A. Antifungale Sordarinderivate
EP0711784A1 (de) * 1994-11-08 1996-05-15 Glaxo, S.A. Antifungale Sordarinderivate
EE9600117A (et) 1994-11-08 1997-04-15 Glaxo Wellcome S.A Antifungaalsed sordariini derivaadid
EP0711783A1 (de) 1994-11-08 1996-05-15 Glaxo, S.A. Antifungale Sordarinderivate
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives

Also Published As

Publication number Publication date
EP1124813A4 (de) 2002-01-23
ES2211191T3 (es) 2004-07-01
EP1124813A1 (de) 2001-08-22
DE69913369T2 (de) 2004-10-14
EP1124813B1 (de) 2003-12-03
US6228622B1 (en) 2001-05-08
ATE255572T1 (de) 2003-12-15
CA2347803A1 (en) 2000-05-04
AU1132000A (en) 2000-05-15
JP2002528444A (ja) 2002-09-03
AU760975B2 (en) 2003-05-22
WO2000024728A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
CA2281001A1 (en) Microbial production of 1,2-propanediol from sugar
CA2359338A1 (en) Bacillus subtilis takemi and use thereof
WO2002091824A8 (en) Biological-chemical fungicide compositions and methods of use
MX336500B (es) Insecticida para uso agricola u horticola y metodo para su uso.
WO2003000051A3 (en) Novel biofungicide
EP2070517A3 (de) Pharmazeutische Zusammensetzungen und Verfahren zur Behandlung von Hypogonadismus
CA2316888A1 (en) Methods of inactivating bacteria including bacterial spores
EP1137755A4 (de) Flüssige pflanzennahrungs-zubereitung mit mikrobiellen stämmen
SE9401307D0 (sv) Composition and method for controlling plant diseases
PL340370A1 (en) Pesticide against pathogenic micro-organism attacking plants
WO2002036815A3 (en) Genetic analysis of microorganisms
DE69913369D1 (de) Mikrobielle transformationsprodukte
CA2252958A1 (en) Fungicide salts
AU4985996A (en) Control of post-harvest fungal disease using saprophytic yeast
AU4747497A (en) Sordarin derivatives
Singh et al. Biochemical profiles of solid state fermented wheat straw with Coprinus fimetarius.
DK1012225T3 (da) Fremgangsmåde og sammensætninger til formindskelse af ödelæggelse af öl
EP1458725A4 (de) Neues, aus kulturfermentierungen isoliertes sordarinderivat und wirkungen als antipilzmittel
WO2004080176A3 (en) Microbicidal compositions including an ionene polymer and 2,4,4’-trichloro-2’-hydroxydiphenyl ether, and methods of using the same
EP0949330A3 (de) Lactobacilli Stämme die eine hemmende Wirkung gegen pathogenische Mikroorganismen besitzen und Verfahren zur induzierung und Behaltung dieser Aktivität in Lactobacillikulturen
WO2001015524A3 (en) Method for controlling bacterial and fungal disease
CA2394365A1 (en) Use of a semicarbazone plant growth regulator for crop yield enhancements
IT1248095B (it) Ceppi batterici di pseudomonas (ncimb 40403, ncimb 40376, ncimb 40375,ncimb 40377, ncimb 40402, ncimb 40379) in grado di controllare le infezioni fungine.
ES2093054T3 (es) Antibioticos ab-023 y procedimiento para su preparacion.
Kuzminsky et al. Toxicological and hygienic evaluation of microorganisms promising for creation of means for agriculture intensification

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee